🔗 Share this article

The top legal official in Texas Paxton is suing the makers of acetaminophen, alleging the corporations concealed safety concerns that the drug created to pediatric brain development.

The court filing arrives thirty days after Donald Trump promoted an unsubstantiated connection between taking acetaminophen - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in children.

The attorney general is taking legal action against the pharmaceutical giant, which once produced the medication, the exclusive pain medication suggested for women during pregnancy, and Kenvue, which now manufacturers it.

In a official comment, he said they "betrayed America by making money from discomfort and marketing drugs without regard for the risks."

The company says there is no credible evidence linking Tylenol to autism.

"These companies deceived for years, deliberately risking numerous people to boost earnings," the attorney general, a Republican, declared.

The company stated officially that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the possible consequences that could have on the health of American women and children."

On its website, the company also said it had "continuously evaluated the applicable studies and there is insufficient valid information that shows a proven link between consuming acetaminophen and autism spectrum disorder."

Organizations representing physicians and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has stated paracetamol - the main ingredient in Tylenol - is among limited choices for women during pregnancy to manage pain and elevated temperature, which can present major wellness concerns if not addressed.

"In multiple decades of investigation on the use of paracetamol in gestation, no reliable research has conclusively proven that the consumption of acetaminophen in any period of gestation causes neurodevelopmental disorders in children," the group commented.

The court filing references recent announcements from the Trump administration in asserting the drug is potentially dangerous.

Recently, Trump caused concern from medical authorities when he told pregnant women to "fight like hell" not to take Tylenol when ill.

The US Food and Drug Administration then released a statement that medical professionals should contemplate reducing the usage of Tylenol, while also mentioning that "a proven link" between the drug and autism spectrum disorder in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who supervises the Food and Drug Administration, had vowed in spring to initiate "a massive testing and research effort" that would establish the cause of autism in a limited time.

But experts advised that identifying a unique factor of autism - considered by experts to be the consequence of a intricate combination of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a type of permanent neurological difference and impairment that impacts how individuals perceive and interact with the world, and is diagnosed using doctors' observations.

In his lawsuit, Paxton - who supports Trump who is campaigning for federal office - asserts the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism.

The case seeks to make the companies "remove any promotional materials" that asserts acetaminophen is secure for pregnant women.

The Texas lawsuit parallels the grievances of a collection of parents of children with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in 2022.

The court rejected the case, declaring studies from the family's specialists was lacking definitive proof.